581 related articles for article (PubMed ID: 8891468)
1. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
Goa KL; Balfour JA; Zuanetti G
Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
[TBL] [Abstract][Full Text] [Related]
2. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
Langtry HD; Markham A
Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
[TBL] [Abstract][Full Text] [Related]
3. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Mazzotta G; Vecchio C
G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
[TBL] [Abstract][Full Text] [Related]
4. Lisinopril: a review of its use in congestive heart failure.
Simpson K; Jarvis B
Drugs; 2000 May; 59(5):1149-67. PubMed ID: 10852646
[TBL] [Abstract][Full Text] [Related]
5. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
Goa KL; Haria M; Wilde MI
Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
[TBL] [Abstract][Full Text] [Related]
6. [Lisinopril: myocardial infarction, the first 24 hours, in patients with stable hemodynamic status. The GISSI-3 study; results at 6 weeks].
Tognoni G
Arch Mal Coeur Vaiss; 1995 Aug; 88 Spec No 3():25-34. PubMed ID: 7503614
[TBL] [Abstract][Full Text] [Related]
7. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.
Zuanetti G; Latini R; Maggioni AP; Franzosi M; Santoro L; Tognoni G
Circulation; 1997 Dec; 96(12):4239-45. PubMed ID: 9416888
[TBL] [Abstract][Full Text] [Related]
8. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
9. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial.
Latini R; Staszewsky L; Maggioni AP; Marino P; Hernandez-Bernal F; Tognoni G; Labarta V; Gramenzi S; Bianchi F; Sarcina G; Cremonesi G; Nicolosi GL; Geraci E;
Am Heart J; 2003 Jul; 146(1):133. PubMed ID: 12851621
[TBL] [Abstract][Full Text] [Related]
12. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
J Am Coll Cardiol; 1996 Feb; 27(2):337-44. PubMed ID: 8557903
[TBL] [Abstract][Full Text] [Related]
13. Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
Plosker GL; McTavish D
Drugs Aging; 1995 Sep; 7(3):226-53. PubMed ID: 8535052
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
Beckwith C; Munger MA
Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
[TBL] [Abstract][Full Text] [Related]
15. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
Young JB
Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
Borghi C; Ambrosioni E;
Am Heart J; 2003 Jan; 145(1):80-7. PubMed ID: 12514658
[TBL] [Abstract][Full Text] [Related]
17. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
[TBL] [Abstract][Full Text] [Related]
18. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.
Lancet; 1994 May; 343(8906):1115-22. PubMed ID: 7910229
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors in heart failure: what more do we need to know?
Demers C; Mody A; Teo KK; McKelvie RS
Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
[TBL] [Abstract][Full Text] [Related]
20. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
Ball SG; Hall AS
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
